VIP-expressing Dendritic Cells Protect Against Spontaneous Autoimmune Peripheral Polyneuropathy

The spontaneous autoimmune peripheral polyneuropathy (SAPP) model in B7-2 knockout nonobese diabetic mice mimics a progressive and unremitting course of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). In this study, bone marrow–derived dendritic cells (DCs) were transduced to expre...

Full description

Saved in:
Bibliographic Details
Published in:Molecular therapy 2014-07, Vol.22 (7), p.1353-1363
Main Authors: Yalvac, Mehmet E, Arnold, William David, Hussain, Syed-Rehan A, Braganza, Cilwyn, Shontz, Kimberly M, Clark, Kelly Reed, Walker, Christopher M, Ubogu, Eroboghene E, Mendell, Jerry R, Sahenk, Zarife
Format: Article
Language:English
Subjects:
Animals
Antigens
Cells, Cultured
Dendritic cells
Dendritic Cells - cytology
Dendritic Cells - metabolism
Dendritic Cells - physiology
Diabetes
Enzymes
Experiments
Gene therapy
Immunoassay
Male
Mice
Original
Peripheral Nervous System Diseases - therapy
Polyneuropathies - therapy
Polypeptides
Vasoactive Intestinal Peptide - metabolism
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c554t-6fcacd06cf0a1e3d01588c16cbf8cdaf53aa67829da4bc26e1ef74afad1cbc983
cites cdi_FETCH-LOGICAL-c554t-6fcacd06cf0a1e3d01588c16cbf8cdaf53aa67829da4bc26e1ef74afad1cbc983
container_end_page 1363
container_issue 7
container_start_page 1353
container_title Molecular therapy
container_volume 22
creator Yalvac, Mehmet E
Arnold, William David
Hussain, Syed-Rehan A
Braganza, Cilwyn
Shontz, Kimberly M
Clark, Kelly Reed
Walker, Christopher M
Ubogu, Eroboghene E
Mendell, Jerry R
Sahenk, Zarife
description The spontaneous autoimmune peripheral polyneuropathy (SAPP) model in B7-2 knockout nonobese diabetic mice mimics a progressive and unremitting course of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). In this study, bone marrow–derived dendritic cells (DCs) were transduced to express vasoactive intestinal polypeptide (VIP) using a lentiviral vector (LV-VIP). These transduced DCs (LV-VIP-DCs) were then injected intravenously (i.v.) into 16-week-old (before disease onset) and 21-week-old (after disease onset) SAPP mice in order to prevent or attenuate the disease. Outcome measures included behavioral tests, clinical and histological scoring, electrophysiology, real-time PCR, flow cytometry analyses, and enzyme-linked immunosorbent assay. LV-VIP-DCs were recruited to the inflamed sciatic nerve and reduced the expression of inflammatory cytokines. A single injection of LV-VIP-DC delayed the onset of disease, stabilized, and attenuated clinical signs correlating with ameliorated behavioral functions, reduced nerve demyelination, and improved nerve conduction. This proof-of-principle study is an important step potentially leading to a clinical translational study using DCs expressing VIP in cases of CIDP refractory to standard immunosuppressive therapy.
doi_str_mv 10.1038/mt.2014.77
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4089012</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1525001616307262</els_id><sourcerecordid>4068615031</sourcerecordid><originalsourceid>FETCH-LOGICAL-c554t-6fcacd06cf0a1e3d01588c16cbf8cdaf53aa67829da4bc26e1ef74afad1cbc983</originalsourceid><addsrcrecordid>eNqFkd1rFDEUxQex2Fp98Q-QAV9KYdbcTD5mXoRlrVoouODHa8hm7uymzCRjkinuf2_K1sWK4NM9cH8c7j2nKF4BWQCpm7djWlACbCHlk-IMOOUVIZQ9PWoQp8XzGG-zAt6KZ8UpZVJQQeVZob5fryv8OQWM0bpt-R5dF2yyplzhMMRyHXxCk8rlVlsXU_ll8i5ph36O5XJO3o7j7LBcY7DTDoMeyrUf9g7n4CeddvsXxUmvh4gvH-Z58e3D1dfVp-rm88fr1fKmMpyzVIneaNMRYXqiAeuOAG8aA8Js-sZ0uue11kI2tO002xgqELCXTPe6A7MxbVOfF-8OvtO8GbEz6FI-Rk3BjjrslddWPd44u1Nbf6cYaVoCNBtcPBgE_2PGmNRoo8kZHJ5VIGRdt4wK-D_KGaVtS6HO6Ju_0Fs_B5eTUCBbYJxDzTN1eaBM8DEG7I93A1H3FasxqfuKlZQZfv3np0f0d6cZYAcAc953FoOKxqIz2NmQq1Sdt__y_QWPBbZl</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1791455135</pqid></control><display><type>article</type><title>VIP-expressing Dendritic Cells Protect Against Spontaneous Autoimmune Peripheral Polyneuropathy</title><source>Open Access: PubMed Central</source><creator>Yalvac, Mehmet E ; Arnold, William David ; Hussain, Syed-Rehan A ; Braganza, Cilwyn ; Shontz, Kimberly M ; Clark, Kelly Reed ; Walker, Christopher M ; Ubogu, Eroboghene E ; Mendell, Jerry R ; Sahenk, Zarife</creator><creatorcontrib>Yalvac, Mehmet E ; Arnold, William David ; Hussain, Syed-Rehan A ; Braganza, Cilwyn ; Shontz, Kimberly M ; Clark, Kelly Reed ; Walker, Christopher M ; Ubogu, Eroboghene E ; Mendell, Jerry R ; Sahenk, Zarife</creatorcontrib><description>The spontaneous autoimmune peripheral polyneuropathy (SAPP) model in B7-2 knockout nonobese diabetic mice mimics a progressive and unremitting course of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). In this study, bone marrow–derived dendritic cells (DCs) were transduced to express vasoactive intestinal polypeptide (VIP) using a lentiviral vector (LV-VIP). These transduced DCs (LV-VIP-DCs) were then injected intravenously (i.v.) into 16-week-old (before disease onset) and 21-week-old (after disease onset) SAPP mice in order to prevent or attenuate the disease. Outcome measures included behavioral tests, clinical and histological scoring, electrophysiology, real-time PCR, flow cytometry analyses, and enzyme-linked immunosorbent assay. LV-VIP-DCs were recruited to the inflamed sciatic nerve and reduced the expression of inflammatory cytokines. A single injection of LV-VIP-DC delayed the onset of disease, stabilized, and attenuated clinical signs correlating with ameliorated behavioral functions, reduced nerve demyelination, and improved nerve conduction. This proof-of-principle study is an important step potentially leading to a clinical translational study using DCs expressing VIP in cases of CIDP refractory to standard immunosuppressive therapy.</description><identifier>ISSN: 1525-0016</identifier><identifier>EISSN: 1525-0024</identifier><identifier>DOI: 10.1038/mt.2014.77</identifier><identifier>PMID: 24762627</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Antigens ; Cells, Cultured ; Dendritic cells ; Dendritic Cells - cytology ; Dendritic Cells - metabolism ; Dendritic Cells - physiology ; Diabetes ; Enzymes ; Experiments ; Gene therapy ; Immunoassay ; Male ; Mice ; Original ; Peripheral Nervous System Diseases - therapy ; Polyneuropathies - therapy ; Polypeptides ; Vasoactive Intestinal Peptide - metabolism</subject><ispartof>Molecular therapy, 2014-07, Vol.22 (7), p.1353-1363</ispartof><rights>2014 American Society of Gene &amp; Cell Therapy</rights><rights>Copyright Nature Publishing Group Jul 2014</rights><rights>Copyright © 2014 American Society of Gene &amp; Cell Therapy 2014 American Society of Gene &amp; Cell Therapy</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c554t-6fcacd06cf0a1e3d01588c16cbf8cdaf53aa67829da4bc26e1ef74afad1cbc983</citedby><cites>FETCH-LOGICAL-c554t-6fcacd06cf0a1e3d01588c16cbf8cdaf53aa67829da4bc26e1ef74afad1cbc983</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089012/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089012/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24762627$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yalvac, Mehmet E</creatorcontrib><creatorcontrib>Arnold, William David</creatorcontrib><creatorcontrib>Hussain, Syed-Rehan A</creatorcontrib><creatorcontrib>Braganza, Cilwyn</creatorcontrib><creatorcontrib>Shontz, Kimberly M</creatorcontrib><creatorcontrib>Clark, Kelly Reed</creatorcontrib><creatorcontrib>Walker, Christopher M</creatorcontrib><creatorcontrib>Ubogu, Eroboghene E</creatorcontrib><creatorcontrib>Mendell, Jerry R</creatorcontrib><creatorcontrib>Sahenk, Zarife</creatorcontrib><title>VIP-expressing Dendritic Cells Protect Against Spontaneous Autoimmune Peripheral Polyneuropathy</title><title>Molecular therapy</title><addtitle>Mol Ther</addtitle><description>The spontaneous autoimmune peripheral polyneuropathy (SAPP) model in B7-2 knockout nonobese diabetic mice mimics a progressive and unremitting course of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). In this study, bone marrow–derived dendritic cells (DCs) were transduced to express vasoactive intestinal polypeptide (VIP) using a lentiviral vector (LV-VIP). These transduced DCs (LV-VIP-DCs) were then injected intravenously (i.v.) into 16-week-old (before disease onset) and 21-week-old (after disease onset) SAPP mice in order to prevent or attenuate the disease. Outcome measures included behavioral tests, clinical and histological scoring, electrophysiology, real-time PCR, flow cytometry analyses, and enzyme-linked immunosorbent assay. LV-VIP-DCs were recruited to the inflamed sciatic nerve and reduced the expression of inflammatory cytokines. A single injection of LV-VIP-DC delayed the onset of disease, stabilized, and attenuated clinical signs correlating with ameliorated behavioral functions, reduced nerve demyelination, and improved nerve conduction. This proof-of-principle study is an important step potentially leading to a clinical translational study using DCs expressing VIP in cases of CIDP refractory to standard immunosuppressive therapy.</description><subject>Animals</subject><subject>Antigens</subject><subject>Cells, Cultured</subject><subject>Dendritic cells</subject><subject>Dendritic Cells - cytology</subject><subject>Dendritic Cells - metabolism</subject><subject>Dendritic Cells - physiology</subject><subject>Diabetes</subject><subject>Enzymes</subject><subject>Experiments</subject><subject>Gene therapy</subject><subject>Immunoassay</subject><subject>Male</subject><subject>Mice</subject><subject>Original</subject><subject>Peripheral Nervous System Diseases - therapy</subject><subject>Polyneuropathies - therapy</subject><subject>Polypeptides</subject><subject>Vasoactive Intestinal Peptide - metabolism</subject><issn>1525-0016</issn><issn>1525-0024</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNqFkd1rFDEUxQex2Fp98Q-QAV9KYdbcTD5mXoRlrVoouODHa8hm7uymzCRjkinuf2_K1sWK4NM9cH8c7j2nKF4BWQCpm7djWlACbCHlk-IMOOUVIZQ9PWoQp8XzGG-zAt6KZ8UpZVJQQeVZob5fryv8OQWM0bpt-R5dF2yyplzhMMRyHXxCk8rlVlsXU_ll8i5ph36O5XJO3o7j7LBcY7DTDoMeyrUf9g7n4CeddvsXxUmvh4gvH-Z58e3D1dfVp-rm88fr1fKmMpyzVIneaNMRYXqiAeuOAG8aA8Js-sZ0uue11kI2tO002xgqELCXTPe6A7MxbVOfF-8OvtO8GbEz6FI-Rk3BjjrslddWPd44u1Nbf6cYaVoCNBtcPBgE_2PGmNRoo8kZHJ5VIGRdt4wK-D_KGaVtS6HO6Ju_0Fs_B5eTUCBbYJxDzTN1eaBM8DEG7I93A1H3FasxqfuKlZQZfv3np0f0d6cZYAcAc953FoOKxqIz2NmQq1Sdt__y_QWPBbZl</recordid><startdate>20140701</startdate><enddate>20140701</enddate><creator>Yalvac, Mehmet E</creator><creator>Arnold, William David</creator><creator>Hussain, Syed-Rehan A</creator><creator>Braganza, Cilwyn</creator><creator>Shontz, Kimberly M</creator><creator>Clark, Kelly Reed</creator><creator>Walker, Christopher M</creator><creator>Ubogu, Eroboghene E</creator><creator>Mendell, Jerry R</creator><creator>Sahenk, Zarife</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><general>Nature Publishing Group</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>7QO</scope><scope>7T5</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>5PM</scope></search><sort><creationdate>20140701</creationdate><title>VIP-expressing Dendritic Cells Protect Against Spontaneous Autoimmune Peripheral Polyneuropathy</title><author>Yalvac, Mehmet E ; Arnold, William David ; Hussain, Syed-Rehan A ; Braganza, Cilwyn ; Shontz, Kimberly M ; Clark, Kelly Reed ; Walker, Christopher M ; Ubogu, Eroboghene E ; Mendell, Jerry R ; Sahenk, Zarife</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c554t-6fcacd06cf0a1e3d01588c16cbf8cdaf53aa67829da4bc26e1ef74afad1cbc983</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Animals</topic><topic>Antigens</topic><topic>Cells, Cultured</topic><topic>Dendritic cells</topic><topic>Dendritic Cells - cytology</topic><topic>Dendritic Cells - metabolism</topic><topic>Dendritic Cells - physiology</topic><topic>Diabetes</topic><topic>Enzymes</topic><topic>Experiments</topic><topic>Gene therapy</topic><topic>Immunoassay</topic><topic>Male</topic><topic>Mice</topic><topic>Original</topic><topic>Peripheral Nervous System Diseases - therapy</topic><topic>Polyneuropathies - therapy</topic><topic>Polypeptides</topic><topic>Vasoactive Intestinal Peptide - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yalvac, Mehmet E</creatorcontrib><creatorcontrib>Arnold, William David</creatorcontrib><creatorcontrib>Hussain, Syed-Rehan A</creatorcontrib><creatorcontrib>Braganza, Cilwyn</creatorcontrib><creatorcontrib>Shontz, Kimberly M</creatorcontrib><creatorcontrib>Clark, Kelly Reed</creatorcontrib><creatorcontrib>Walker, Christopher M</creatorcontrib><creatorcontrib>Ubogu, Eroboghene E</creatorcontrib><creatorcontrib>Mendell, Jerry R</creatorcontrib><creatorcontrib>Sahenk, Zarife</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Proquest Health &amp; Medical Complete</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>Biotechnology Research Abstracts</collection><collection>Immunology Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Molecular therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yalvac, Mehmet E</au><au>Arnold, William David</au><au>Hussain, Syed-Rehan A</au><au>Braganza, Cilwyn</au><au>Shontz, Kimberly M</au><au>Clark, Kelly Reed</au><au>Walker, Christopher M</au><au>Ubogu, Eroboghene E</au><au>Mendell, Jerry R</au><au>Sahenk, Zarife</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>VIP-expressing Dendritic Cells Protect Against Spontaneous Autoimmune Peripheral Polyneuropathy</atitle><jtitle>Molecular therapy</jtitle><addtitle>Mol Ther</addtitle><date>2014-07-01</date><risdate>2014</risdate><volume>22</volume><issue>7</issue><spage>1353</spage><epage>1363</epage><pages>1353-1363</pages><issn>1525-0016</issn><eissn>1525-0024</eissn><abstract>The spontaneous autoimmune peripheral polyneuropathy (SAPP) model in B7-2 knockout nonobese diabetic mice mimics a progressive and unremitting course of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). In this study, bone marrow–derived dendritic cells (DCs) were transduced to express vasoactive intestinal polypeptide (VIP) using a lentiviral vector (LV-VIP). These transduced DCs (LV-VIP-DCs) were then injected intravenously (i.v.) into 16-week-old (before disease onset) and 21-week-old (after disease onset) SAPP mice in order to prevent or attenuate the disease. Outcome measures included behavioral tests, clinical and histological scoring, electrophysiology, real-time PCR, flow cytometry analyses, and enzyme-linked immunosorbent assay. LV-VIP-DCs were recruited to the inflamed sciatic nerve and reduced the expression of inflammatory cytokines. A single injection of LV-VIP-DC delayed the onset of disease, stabilized, and attenuated clinical signs correlating with ameliorated behavioral functions, reduced nerve demyelination, and improved nerve conduction. This proof-of-principle study is an important step potentially leading to a clinical translational study using DCs expressing VIP in cases of CIDP refractory to standard immunosuppressive therapy.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>24762627</pmid><doi>10.1038/mt.2014.77</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1525-0016
ispartof Molecular therapy, 2014-07, Vol.22 (7), p.1353-1363
issn 1525-0016
1525-0024
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4089012
source Open Access: PubMed Central
subjects Animals
Antigens
Cells, Cultured
Dendritic cells
Dendritic Cells - cytology
Dendritic Cells - metabolism
Dendritic Cells - physiology
Diabetes
Enzymes
Experiments
Gene therapy
Immunoassay
Male
Mice
Original
Peripheral Nervous System Diseases - therapy
Polyneuropathies - therapy
Polypeptides
Vasoactive Intestinal Peptide - metabolism
title VIP-expressing Dendritic Cells Protect Against Spontaneous Autoimmune Peripheral Polyneuropathy
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T04%3A00%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=VIP-expressing%20Dendritic%20Cells%20Protect%20Against%20Spontaneous%20Autoimmune%20Peripheral%20Polyneuropathy&rft.jtitle=Molecular%20therapy&rft.au=Yalvac,%20Mehmet%20E&rft.date=2014-07-01&rft.volume=22&rft.issue=7&rft.spage=1353&rft.epage=1363&rft.pages=1353-1363&rft.issn=1525-0016&rft.eissn=1525-0024&rft_id=info:doi/10.1038/mt.2014.77&rft_dat=%3Cproquest_pubme%3E4068615031%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c554t-6fcacd06cf0a1e3d01588c16cbf8cdaf53aa67829da4bc26e1ef74afad1cbc983%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1791455135&rft_id=info:pmid/24762627&rfr_iscdi=true